Sensei Biotherapeutics, Inc. [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	10.2	11.0	13.9	10.7	12.5	3.5	10.3	9.8
General and administrative						3.5
Research and development						6.0
Other operating expenses	-10.2	-11.0	-13.9	-10.7	-12.5	0.0	-10.3	-9.8
EBITDA [+]	0.1	0.2	0.2	0.1	0.2	-9.1	0.1	0.1
EBITDA growth	-4.2%	2.5%	11.0%	18.0%	60.2%	81.0%	-102.6%	-103.0%
Depreciation and amortization	0.1	0.2	0.2	0.1	0.2	0.3	0.1	0.1
EBIT [+]	0.0	0.0	0.0	0.0	0.0	-9.4	0.0	0.0
EBIT growth						85.0%	-100.0%	-100.0%
Non-recurring items [+]						0.0
Loss (gain) on sale of assets						0.0
Interest income, net [+]	1.0	1.0	0.5	0.3	0.3	0.0	0.3	0.2
Interest expense	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.1
Interest income	1.0	1.0	0.5	0.3	0.3	0.3	0.3	0.2
Other income (expense), net	-10.3	-11.1	-13.9	-10.7	-12.5	0.0	-9.7	-9.8
Pre-tax income	-9.4	-10.2	-13.4	-10.5	-12.4	-9.4	-9.7	-9.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-9.4	-10.2	-13.4	-10.5	-12.4	-9.4	-9.7	-9.8

Basic EPS [+]	($0.31)	($0.33)	($0.44)	($0.34)	($0.40)	($0.34)	($0.32)	($0.32)
Growth	-10.3%	-18.5%	37.9%	7.4%	-4.0%	-89.4%	-89.5%	-89.4%
Diluted EPS [+]	($0.31)	($0.33)	($0.44)	($0.34)	($0.40)	($0.34)	($0.32)	($0.32)
Growth	-10.3%	-18.5%	37.9%	7.4%	-4.0%	-89.4%	-89.5%	-89.4%

Shares outstanding (basic) [+]	30.5	30.9	30.7	30.7	30.6	27.7	30.6	30.6
Growth	-0.6%	0.7%	0.4%	0.4%	62.1%	1618.9%	1611.6%	1782.4%
Shares outstanding (diluted) [+]	30.5	30.9	30.7	30.7	30.6	27.7	30.6	30.6
Growth	-0.6%	0.7%	0.4%	0.4%	62.1%	1618.9%	1611.6%	1782.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.